ROCKET-AF: Rivaroxaban Noninferior to Warfarin in AF Patients

Authors : Manesh R. Patel, M.D.; Kenneth W. Mahaffey, M.D.; Jyotsna Garg, M.S.; Guohua Pan, Ph.D.; Daniel E. Singer, M.D.; Werner Hacke, M.D., Ph.D.; Günter Breithardt, M.D.; Jonathan L. Halperin, M.D.; Graeme J. Hankey, M.D.; Jonathan P. Piccini, M.D.; Richard C. Becker,M.D.; Christopher C. Nessel,M.D.; John F. Paolini, M.D., Ph.D.; Scott D. Berkowitz, M.D.; Keith A.A. Fox, M.B., Ch.B.; Robert M. Califf,M.D.;

Affiliations : Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA. manesh.patel@duke.edu

Journal : The New England Journal of medicine   (2011)

Related Links: Pubmed | Publisher website

Defects in Ankyrin-Based Membrane Protein Targeting Pathways Underlie Atrial Fibrillation

Authors : Shane R. Cunha, PhD; Thomas J. Hund, PhD; Seyed Hashemi, MD; Niels Voigt, MD; Na Li, MD; Patrick Wright, BS; Olha Koval, PhD; Jingdong Li, MD; Hjalti Gudmundsson, MD; Richard J. Gumina, MD, PhD; Matthias Karck, MD; Jean-Jacques Schott, PhD; Vincent Probst, MD, PhD; Herve Le Marec, MD, PhD; Mark E. Anderson, MD, PhD; Dobromir Dobrev, MD; Xander H.T. Wehrens, MD, PhD;

Affiliations : Correspondence to Peter J. Mohler, PhD, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Medical Center, 473 W 12th Ave, 110G DHLRI, Columbus, OH 43210. E-mail peter.mohler@osumc.edu

Journal : Circulation   (2011)

Related Links: Pubmed | Publisher website

Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death

Authors :

Affiliations : "Correspondence to Professor Richard J Schilling, Cardiology Department, Barts and The London NHS Trust QMUL, St Bartholomew's Hospital, London EC1A 7BE, UK; r.schilling@qmul.ac.uk "

Journal : Original article   (2011)

Related Links: Pubmed | Publisher website

Long-term outcome after catheter ablation for atrial fibrillation: safety, efficacy and impact on prognosis

Authors :

Affiliations : Correspondence to Professor Richard J Schilling, Cardiology Research Department, Barts and The London NHS Trust and QMUL, St Bartholomew's Hospital, First Floor Dominion House, 60 Bartholomew Close, West Smithfield, London EC1A 7BE, UK; r.schilling@qmul.ac.uk

Journal : Original article   (2010)

Related Links: Pubmed | Publisher website

An Underrecognized Trigger Site of Atrial Fibrillation

Authors : J. David Burkhardt, MD; Prasant Mohanty, MBBS, MPH; Javier Sanchez, MD; Sanghamitra Mohanty, MD; Rodney Horton, MD; G. Joseph Gallinghouse, MD; Shane M. Bailey, MD; Jason D. Zagrodzky, MD; Pasquale Santangeli, MD; Steven Hao, MD; Richard Hongo, MD; Salwa Beheiry, MD; Sakis Themistoclakis, MD; Aldo Bonso, MD; Antonio Rossillo, MD; Andrea Corrado, MD; Antonio Raviele, MD; Amin Al-Ahmad, MD; Paul Wang, MD; Jennifer E. Cummings, MD; Robert A. Schweikert, MD; Gemma Pelargonio, MD; Antonio Dello Russo, MD; Michela Casella, MD; Pietro Santarelli, MD; William R. Lewis, MD;

Affiliations : Correspondence to Andrea Natale, MD, Executive Medical Director, Texas Cardiac Arrhythmia Institute, St. David’s Medical Center, 1015 E 32nd St, Suite 516, Austin, TX 78705. E-mail dr.natale@gmail.com

Journal : Arrhythmia/Electrophysiology   (2010)

Related Links: Pubmed | Publisher website

Advances in the hospital management of patients following an out of hospital cardiac arrest

Authors :

Affiliations : Dr Pascal Meier, Director Yale, UCL Device Development Program, The Heart Hospital London, University College London Hospital Trust, London, UK; pascalmeier74@gmail.com

Journal : N/A   (2012 )

Related Links: Pubmed | Publisher website

Relationship of Sudden Cardiac Death to New-Onset Atrial Fibrillation in Hypertensive Patients With Left Ventricular Hypertrophy

Authors :

Affiliations : Correspondence to Peter M. Okin, MD, Weill Medical College of Cornell University, 525 East 68th St, New York, NY 10065. E-mail pokin@med.cornell.edu

Journal : N/A   (2013)

Related Links: Pubmed | Publisher website

Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines

Authors :

Affiliations : Division of Clinical Sciences, St George's University of London, London, UK Medical Writers Group, LLC, New York, USA

Journal : N/A   (2013)

Related Links: Pubmed | Publisher website

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

Authors :

Affiliations : University of Birmingham Centre for Cardiovascular Sciences and SWBH NHS Trust, Institute for Biomedical Research, 1st Floor, Room 136, Birmingham B15 2TT, UK University Hospital Münster, Münster, Germany AFNET, Germany CHU de Nancy, Nancy, France Duke University School of Medicine, Durham, NC, USA Fondazione Cardiocentro Ticino, Lugano, Switzerland St. Jude Medical, St. Paul, MN, USA Department of Cardiology, University of Leiden Medical Center, Leiden, NL, The Netherlands Department of Cardiology, Institution of Medical Science, Uppsala University, Uppsala, Sweden St. Antonius Hospital, Nieuwegein, The Netherlands University of Bologna, Bologna, Italy Odense University Hospital, Odense, Denmark Meda Pharma SAS, Paris, France University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany The Johns Hopkins Hospital, Baltimore, MD, USA University of Oxford, Oxford, UK University Hospital Maastricht, Maastricht, The Netherlands Daiichi Sankyo Europe GmbH, Munich, Germany University Duisburg-Essen, Essen, Germany Lankenau Institute for Medical Research, Wynnewood, PA, USA CRI—The Clinical Research Institute, Munich, Germany Ludwig Maximilian University, Munich, Germany University of Calgary/Libin, Calgary, Alberta, Canada Garibaldi-Nesima Hospital, Catania, Italy Bristol-Myers Squibb, Munich, Germany University Hospital Zurich, Zurich, Switzerland Faculté de Médecine Pitié-Salpêtrière, Paris, France Charité Berlin, Berlin, Germany University Hospital Gasthuisberg, Leuven, Belgium Hôpital Cardologique du Haut-Lévêque and the Université Victor Segalen Bordeaux II, Bordeaux, France University of Lausanne, Lausanne, Switzerland Institute for Clinical and Experimental Medicine, Prague, Czech Republic Klinik St. Georg, Hanseatisches Herzzentrum, Hamburg, Germany Isar Herzzentrum, Munich, Germany Medtronic International Trading Sàrl, Tolochenaz, Switzerland Hospital Clínic, University of Barcelona, Barcelona, Spain Pfizer Deutschland GmbH, Berlin, Germany Aarhus University Hospital, Aarhus, Denmark Städtisches Klinikum Brandenburg, Brandenburg, Germany Hacettepe University Faculty of Medicine, Ankara, Turkey Medizinische Universität Graz, Graz, Austria University of Belgrade, Belgrade, Serbia TU Dresden, Dresden, Germany Columbia University Medical Center, New York, NY, USA Bristol-Myers Squibb, Rueil-Malmaison, Paris, France Bayer Vital GmbH, Leverkusen, Germany St. Jude Medical, Zaventem, Belgium Boston Scientific, St. Paul, MN, USA Zentrum für Kardiologie am Klinikum Starnberg, Starnberg, Germany Institute of Cardiology, Warsaw, Poland Ettore Sansavini Health Science Foundation, Cotignola, Italy Ospedale dell'Angelo, Mestre-Venice, Venice, Italy Bayer Pharma AG, Berlin, Germany University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Sanofi Aventis Deutschland GmbH, Berlin, Germany University College Hospital, London, UK University Heart Center Hamburg, Hamburg, Germany St. George's Hospital Medical School, London, UK

Journal : N/A   (2013)

Related Links: Pubmed | Publisher website

Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial

Authors :

Affiliations : Department of Cardiology, Maastricht University Medical Centre, PO Box 5800 6202 AZ, Maastricht, The Netherlands Department of Cardiology, J. W. Goethe University Hospital, Frankfurt, Germany McMaster University, Population Health Research Institute, Hamilton, Ontario, Canada Institute of Health, Science and Technology, Aalborg University, Aalborg Øst, Denmark Sanofi, Paris, France University of Washington, Seattle, USA

Journal : N/A   (2013)

Related Links: Pubmed | Publisher website

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the

Authors : Julius M. Gardin, MD, Vice Chair; Jonathan Abrams, MD; Kathleen Berra, MSN, ANP; James C. Blankenship, MD; Apostolos P. Dallas, MD; Pamela S. Douglas, MD; JoAnne M. Foody, MD; Thomas C. Gerber, MD, PhD; Alan L. Hinderliter, MD; Spencer B. King III, MD; Paul D. Kligfield, MD; Harlan M. Krumholz, MD; Raymond Y.K. Kwong, MD; Michael J. Lim, MD; Jane A. Linderbaum, MS, CNP-BC; Michael J. Mack, MD; Mark A. Munger, PharmD; Richard L. Prager, MD; Joseph F. Sabik, MD; Leslee J. Shaw, PhD; Joanna D. Sikkema, MSN, ANP-BC; Craig R. Smith Jr, MD; Sidney C. Smith Jr, MD; John A. Spertus, MD, MPH;

Affiliations : N/A

Journal : N/A   (2012)

Related Links: Pubmed | Publisher website

Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients With Decompensated Heart Failure

Authors :

Affiliations : From the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (B.D.N., G.A.W., M.A.M., M.E.J., R.L.V.); Brown University, Providence, RI (G.A.W.); and University of Cincinnati College of Medicine, Cincinnati, OH (A.J.B.).

Journal : N/A   (2011)

Related Links: Pubmed | Publisher website

A Statement for Health Care Professionals From the American Association of Cardiovascular and Pulmonary Rehabilitation and the American Heart Association

Authors : Vera Bittner, MD, MSPH; Richard Josephson, MD; Karen Lui, RN, MS; Randal J. Thomas, MD, MS;

Affiliations : From Helen Hayes Hospital, West Haverstraw, New York, and Columbia University, New York, New York (M.K.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham (V.B.); Harrington Heart and Vascular Institute, University Hospitals Case Medical Center, and Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio (R.J.); Governmental Representation with Quality, LLC, Vienna, Virginia (K.L.); Cardiovascular Health Clinic, Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota (R.J.T.); and Division of Cardiology, Creighton University School of Medicine, Omaha, Nebraska (M.A.W.).

Journal : N/A   (2012)

Related Links: Pubmed | Publisher website

Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition a

Authors : Daniel Lindholm, MD; Agneta Siegbahn, MD, PhD; Lisa Wernroth, MSc; Richard C. Becker, MD; Christopher P. Cannon, MD; Jan H. Cornel, MD, PhD; Anders Himmelmann, MD, PhD; Evangelos Giannitsis, MD; Robert A. Harrington, MD; Claes Held, MD, PhD; Steen Husted, MD, DSc; Hugo A. Katus, MD; Kenneth W. Mahaffey, MD; Ph. Gabriel Steg, MD; Robert F. Storey, MD, DM; Stefan K. James, MD, PhD;

Affiliations : Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (L.W., D.L., L.W., C.H., S.K.J.); Department of Medical Sciences, Clinical Chemistry and Uppsala Clinical Research Center Uppsala University, Uppsala, Sweden (A.S.); Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, Academic Health Center, Cincinnati, OH (R.C.B.); Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (C.P.C.); Department of Cardiology, Medisch Centrum Alkmaar, Alkmaar, Netherlands (J.H.C.); AstraZeneca Research and Development, Mölndal, Sweden (A.H.); Medizinische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany (E.G., H.A.K.); Medical Department, Hospital Unit West, Herning/Holstbro, Denmark (S.H.); INSERM-Unité 698, Paris, France; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, UK (P.G.S.); and Department of Cardiovascular Science, University of Sheffield, Sheffield, UK (R.F.S.).

Journal : N/A   (2014)

Related Links: Pubmed | Publisher website

Sexual Activity and Cardiovascular Disease A Scientific Statement From the American Heart Association

Authors : Chair; Elaine E. Steinke, RN, PhD, FAHA; Faisal G. Bakaeen, MD; Biykem Bozkurt, MD, PhD, FAHA; Melvin D. Cheitlin, MD, FAHA; Jamie Beth Conti, MD; Elyse Foster, MD, FAHA; Tiny Jaarsma, RN, PhD, FAHA; Robert A. Kloner, MD, PhD; Richard A. Lange, MD, MBA, FAHA; Stacy Tessler Lindau, MD; Barry J. Maron, MD; Debra K. Moser, DNSc, RN, FAHA; E. Magnus Ohman, MD; Allen D. Seftel, MD;

Affiliations : N/A

Journal : N/A   (2012)

Related Links: Pubmed | Publisher website